[Is lifetime anticoagulation required in factor V Leiden mutation?].
Pötzsch
Bernd
B
Institüt für Experimentelle Hämatologie und Transfusionmedizin, Universitätklinikum Bonn. bernd.poetzsch@ukb.uni-bonn.de
D020016:Activated Protein C Resistance / Q000235:genetics*; D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D005165:Factor V / Q000235:genetics*; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D008134:Long-Term Care; D017354:Point Mutation / Q000235:genetics*; D019851:Thrombophilia / Q000188:drug therapy / Q000235:genetics*
D000925:Anticoagulants; C095381:factor V Leiden; D005165:Factor V